Shopping Cart

Your shopping cart is currently empty

PAOPA

Name: PAOPA
Brand: TargetMol
SKU: T23121
Price: 148 USD
Availability: InStock
Rating: 5 (10 reviews)

Copy Product Info

🥰Excellent

Catalog No. T23121Cas No. 114200-31-6

PAOPA is a novel dopamine D2 receptor modulator and L-proline-L-leucine-glycine amide (PLG) peptide mimetic that prevents and reverses behavioral and biochemical abnormalities in preclinical animal models of schizophrenia sensitized to amphetamine. PAOPA has been used in the study of schizophrenia and extrapyramidal dysfunction.

PAOPA

Copy Product Info

🥰Excellent

Catalog No. T23121Cas No. 114200-31-6

Pack Size	Price	USA Warehouse	Global Warehouse
1 mg	$148	In Stock	In Stock
5 mg	$372	In Stock	In Stock
10 mg	$612	In Stock	In Stock
25 mg	$1,290	In Stock	In Stock
50 mg	$1,980	In Stock	In Stock
100 mg	$2,790	In Stock	In Stock

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Batch Information

Select Batch

Purity:>99.99%

ee:99.84%

Appearance:Solid

Color:White to Yellow

Resource Download

COA CSFC HNMR LCMS

Product Introduction

Bioactivity

Description	PAOPA is a novel dopamine D2 receptor modulator and L-proline-L-leucine-glycine amide (PLG) peptide mimetic that prevents and reverses behavioral and biochemical abnormalities in preclinical animal models of schizophrenia sensitized to amphetamine. PAOPA has been used in the study of schizophrenia and extrapyramidal dysfunction.
In vitro	10 μM PAOPA, treated for 1.5 hr increased striatal expression of GRK2 in D2/eYFP-labeled cells and promoted expression of arrestin-3, phosphorylated ERK1 and ERK2. 10 μM PAOPA, treated for 48 h then promoted internalization of D2 receptors in D2/eYFP-labeled cells. [1]
In vivo	In chronic administration, intraperitoneal injection of 1 mg/kg PAOPA once daily for 45 days enhanced D2 receptor modulation and up-regulated the expression of downstream molecules (e.g., GRK2, arrestin-3, and phosphorylated ERK 1/2) in mice. [1]

Chemical Properties

Molecular Weight	254.29
Formula	C₁₁H₁₈N₄O₃
Cas No.	114200-31-6
Smiles	N(C(=O)[C@@H]1CCCN1)[C@H]2C(=O)N(CC(N)=O)CC2
Relative Density.	1.33 g/cm3 (Predicted)

Storage & Solubility Information

Storage

keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

DMSO: 45 mg/mL (176.96 mM), Sonication is recommended.

H2O: <25.43 mg/mL, Sonication is recommended.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	3.9325 mL	19.6626 mL	39.3252 mL	196.6259 mL
5 mM	0.7865 mL	3.9325 mL	7.8650 mL	39.3252 mL
10 mM	0.3933 mL	1.9663 mL	3.9325 mL	19.6626 mL
20 mM	0.1966 mL	0.9831 mL	1.9663 mL	9.8313 mL
50 mM	0.0787 mL	0.3933 mL	0.7865 mL	3.9325 mL
100 mM	0.0393 mL	0.1966 mL	0.3933 mL	1.9663 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc